Development asset linked to Zentalis Pharmaceuticals in public FDA and regional records.
pharma · Ovarian Cancer · Breast Cancer · ZNTL
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
10275 Science Center Dr, Suite 200, San Diego, California 92121, US HQ
123 Employees
Public company Type
ZNTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10275 Science Center Dr, Suite 200, San Diego, California 92121, US
- Employees
- 123
- Programs
- 14
- Drugs
- 4
- Patents
- 0
Zentalis Pharmaceuticals pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Zentalis Pharmaceuticals drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Zentalis Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Zentalis Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Zentalis Pharmaceuticals in public FDA and regional records.